1. Metabolic Enzyme/Protease Epigenetics Cell Cycle/DNA Damage
  2. Endogenous Metabolite Sirtuin
  3. Nicotinic acid mononucleotide

Nicotinic acid mononucleotide 是一种 SARM1 抑制剂和 NAD+ 生物合成中间体,对 SARM1IC50 值为 93.3 μM。Nicotinic acid mononucleotide 具有轴突保护作用,可延缓轴突变性、提升 NAD+ 水平、增强 Sirt1 活性、改善心肌毛细血管密度并缓解心肌纤维化。Nicotinic acid mononucleotide 可通过升高心肌 NAD+ 水平,逆转糖尿病小鼠的糖尿病心肌病。Nicotinic acid mononucleotide 可用于癌症、多发性硬化症、糖尿病性心肌病、神经退行性疾病以及亨廷顿舞蹈症的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Nicotinic acid mononucleotide

Nicotinic acid mononucleotide Chemical Structure

CAS No. : 321-02-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
5 mg ¥1520
In-stock
10 mg ¥2800
In-stock
25 mg ¥5760
In-stock
50 mg 现货 询价
100 mg 现货 询价
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Other Forms of Nicotinic acid mononucleotide:

MCE 顾客使用本产品发表的 1 篇科研文献

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Nicotinic acid mononucleotide acts as a SARM1 inhibitor and a NAD+ biosynthesis intermediate, with an IC50 value of 93.3 μM against SARM1. Nicotinic acid mononucleotide exerts axon-protective effects, delays axonal degeneration, elevates NAD+ levels, enhances Sirt1 activity, improves myocardial capillary density and alleviates myocardial fibrosis. Nicotinic acid mononucleotide reverses diabetic cardiomyopathy in diabetic mice by increasing myocardial NAD+ levels. Nicotinic acid mononucleotide is applicable to research related to cancer, multiple sclerosis, diabetic cardiomyopathy, neurodegenerative diseases and Huntington's disease[1][2][3][4].

体外研究
(In Vitro)

Nicotinic acid mononucleotide (0-250 μM; assay duration) 可通过结合 N 端 ARM 结构域抑制全长人源 SARM1 NAD+水解酶活性;在无 NMN 的条件下其 IC50 为 93.3 μM,而在存在 5 μM NMN 的条件下该抑制作用减弱 (IC50 = 147.2 μM)[1]
Nicotinic acid mononucleotide 通过恢复降低的细胞内 NAD+ 水平延缓哺乳动物轴突的轴突变性[3]
Nicotinic acid mononucleotide (NAM) 可增加高糖处理的人脐静脉内皮细胞 (HUVECs) 中 Sirt1 的表达及 eNOS 的磷酸化水平[4]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Nicotinic acid mononucleotide (NAM) (400 mg/kg/day; i.p.; daily; 8 weeks) 可通过升高心肌 NAD+ 水平、改善心脏功能与超微结构、增加毛细血管密度、减轻纤维化及恢复 Sirt1 表达,部分逆转 Streptozotocin (HY-13753) 诱导的糖尿病小鼠的糖尿病心肌病[4]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J (8-week-old male; streptozotocin-induced diabetic)[4]
Dosage: 400 mg/kg/day
Administration: i.p.; daily; 8 weeks
Result: Partially increased myocardial NAD+ levels in diabetic mice.
Partially reversed impaired left ventricular ejection fraction (LVEF) and fractional shortening (FS) relative to untreated diabetic mice.
Improved myocardial ultrastructural abnormalities (reduced Z-line misalignment, mitochondrial swelling, and myofibril disorganization).
Increased myocardial capillary density relative to untreated diabetic mice.
Reduced myocardial expression of fibrosis markers TGF-β1 and collagen I relative to untreated diabetic mice.
Restored myocardial Sirt1 mRNA and protein expression relative to untreated diabetic mice.
Had no effect on blood glucose or body weight in diabetic mice, and no significant effect on interventricular septal thickness (IVSD) or left ventricular posterior wall thickness (LVPWD).
分子量

335.20

Formula

C11H14NO9P

CAS 号
性状

固体

颜色

White to off-white

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
细胞实验: 

H2O 中的溶解度 : 10 mg/mL (29.83 mM; 超声助溶)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.9833 mL 14.9165 mL 29.8329 mL
5 mM 0.5967 mL 2.9833 mL 5.9666 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
您所需的储备液浓度超过该产品的实测溶解度,如有需要,请与 MCE 中国技术支持联系。
纯度 & 产品资料
参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 2.9833 mL 14.9165 mL 29.8329 mL 74.5823 mL
5 mM 0.5967 mL 2.9833 mL 5.9666 mL 14.9165 mL
10 mM 0.2983 mL 1.4916 mL 2.9833 mL 7.4582 mL
15 mM 0.1989 mL 0.9944 mL 1.9889 mL 4.9722 mL
20 mM 0.1492 mL 0.7458 mL 1.4916 mL 3.7291 mL
25 mM 0.1193 mL 0.5967 mL 1.1933 mL 2.9833 mL

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Nicotinic acid mononucleotide
目录号:
HY-128700
需求量:

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

A B C F G H J L N Q S T X Y Z